Replies to post #254418 on The Golden Lounge

[Theo]

Yep :-D : Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

: Amicus Therapeutics announces positive Phase 3 data From Fabry Monotherapy study 012; Migalastat successfully meets both co-primary endpoints of comparability to enzyme replacement therapy on both key measures of kidney function

: Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012

[Theo]

Big short position (24%) here too ;-) Gonna add if they (shorts) can keep it close to $5 at the open. This gonna be a good one me thinks.